Literature DB >> 12855033

Analysis of the referral pattern to a supraregional bone and soft tissue tumour service.

N Ashwood1, J D Witt, P J Hallam, J P Cobb.   

Abstract

AIM: To investigate the sources of delay in diagnosis and determine if there was a similar diagnostic error rate as found by the Musculoskeletal Tumour Society, which subsequently altered patients' management and affected outcome. PATIENTS AND METHODS: A prospective review of 100 consecutive patients referred to our institution analysed causes for delay in referral and whether prior investigations or procedures had complicated further management.
RESULTS: Patients were symptomatic for 14.8 months (range, 0-26 months) prior to consultation with their GP. A further 13.5 months (range, 0.5-120 months) elapsed before referral by the local hospital (94) or GP (6) to the bone and soft tissue service. A significant delay in referral of more than a month occurred in 72 patients. Those patients with malignant disease were symptomatic for 7.6 months (range, 0.5-11 months) prior to seeking medical advice with a further 7.5 months (range, 0-13 months) elapsing prior to onward referral at their local hospital. From the study group, 63 patients were subjected to complex imaging studies (bone scan, CT, MRI) prior to referral; 34 biopsies or surgery were performed in 34 cases by referring teams, 16 of which complicated subsequent management.
CONCLUSIONS: If a high suspicion of a soft tissue or bone tumour is suspected from the history, examination and plain radiograph, then early referral to a specialist centre is recommended where relevant, high-quality investigations can be arranged in a short time leading to a planned biopsy, confirmation of diagnosis and definitive treatment at an earlier stage.

Entities:  

Mesh:

Year:  2003        PMID: 12855033      PMCID: PMC1964394          DOI: 10.1308/003588403766275015

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  8 in total

Review 1.  [Cartilage tumors of the skeleton].

Authors:  G Jundt; D Baumhoer
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

2.  The Impact of Pre-Referral Advanced Diagnostic Testing on Wait Time to See a Hand Surgeon for Common Upper-Extremity Conditions.

Authors:  Yu-Ting Lu; Steven C Haase; Ting-Ting Chung; Kevin C Chung; Erika D Sears
Journal:  J Hand Surg Am       Date:  2019-10-31       Impact factor: 2.230

3.  Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.

Authors:  Anne A Smartt; Eugene S Jang; Wakenda K Tyler
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

4.  Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?

Authors:  A George; R Grimer
Journal:  Ann R Coll Surg Engl       Date:  2012-05       Impact factor: 1.891

5.  Imaging investigations before referral to a sarcoma center delay the final diagnosis of musculoskeletal sarcoma.

Authors:  Heidi Buvarp Dyrop; Peter Vedsted; Mathias Rædkjær; Akmal Safwat; Johnny Keller
Journal:  Acta Orthop       Date:  2017-01-12       Impact factor: 3.717

6.  Use of Healthcare Services Two Years before Diagnosis in Danish Sarcoma Patients, 2000-2013.

Authors:  Mathias Rædkjær; Katja Maretty-Kongstad; Thomas Baad-Hansen; Akmal Safwat; Michael M Petersen; Johnny Keller; Peter Vedsted
Journal:  Sarcoma       Date:  2019-05-07

7.  The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes.

Authors:  Vicky Soomers; Olga Husson; Robin Young; Ingrid Desar; Winette Van der Graaf
Journal:  ESMO Open       Date:  2020-02

8.  Perspectives of primary health care physicians on diagnosing and referring patients with apparent osteolytic lesions on plain X-ray films: a cross-sectional study.

Authors:  Ali Alyami; Yasser Alshomrani; Rayyan Suqaty; Shaddy Futtiny; Faisal Alnaqib; Muath Albarakati; Ahmad Alhazmi
Journal:  Adv Med Educ Pract       Date:  2016-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.